Atlanta, GA73 Active Studies

Pulmonary Hypertension Clinical Trials in Atlanta, GA

Find 73 actively recruiting pulmonary hypertension clinical trials in Atlanta, GA. Connect with local research sites and explore new treatment options.

73
Active Trials
55
Sponsors
48,320
Enrolling

Recruiting Pulmonary Hypertension Studies in Atlanta

About Pulmonary Hypertension Clinical Trials in Atlanta

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 73 pulmonary hypertension clinical trials recruiting participants in Atlanta, GA. These studies are seeking a combined 48,320 participants. Research is being sponsored by Centers for Disease Control and Prevention, Pulmonary Hypertension Association, Inc., Children's Oncology Group and 52 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Atlanta — FAQ

Are there pulmonary hypertension clinical trials in Atlanta?

Yes, there are 73 pulmonary hypertension clinical trials currently recruiting in Atlanta, GA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Atlanta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Atlanta research site will contact you about next steps.

Are clinical trials in Atlanta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Atlanta studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 73 active trials in Atlanta are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated October 23, 2026 from ClinicalTrials.gov